Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C. B. Westphalen,
M. G. Krebs,
C. Le Tourneau,
E. S. Sokol,
S. L. Maund,
T. R. Wilson,
D. X. Jin,
J. Y. Newberg,
D. Fabrizio,
L. Veronese,
M. Thomas,
F. de Braud
Affiliations
C. B. Westphalen
Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich
M. G. Krebs
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre
C. Le Tourneau
Department of Drug Development and Innovation (D3i), Institut Curie, Paris & Saint-Cloud, France
E. S. Sokol
Foundation Medicine Inc.
S. L. Maund
Genentech Inc.
T. R. Wilson
Genentech Inc.
D. X. Jin
Foundation Medicine Inc.
J. Y. Newberg
Foundation Medicine Inc.
D. Fabrizio
Foundation Medicine Inc.
L. Veronese
F. Hoffmann-La Roche Ltd
M. Thomas
F. Hoffmann-La Roche Ltd
F. de Braud
Department of Medical Oncology and Haematology, Fondazione IRCCS Istituto Nazionale dei Tumori
